Healthscope receives rival takeover offer

Company News

by Anna Napoli

Private healthcare provider, Healthscope (ASX:HSO) has received a rival takeover offer from private equity firm Brookfield.

Brookfield is offering $2.50 per share, which is a premium of 23 per cent to the company’s closing price on the 24th of April.

A consortium of investors offered a price of $2.36 per share for the company last month.

The Brookfield proposal is still subject to a number of conditions including due diligence.

Shares in Healthscope (ASX:HSO) are trading up 3.64 per cent to $2.56
 

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.